Summary & Overview
HCPCS S3708: Gastrointestinal Fat Absorption Study
HCPCS Level II code S3708 denotes a gastrointestinal fat absorption study, a diagnostic test used to evaluate fat malabsorption and related disorders of digestion. Nationally, this code matters because it identifies services used in the workup of chronic diarrhea, failure to thrive, unexplained weight loss, and conditions such as pancreatic insufficiency and celiac disease, helping clinicians and payers distinguish specialized laboratory testing from routine panels.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for use of the code, typical sites of service, and payer coverage themes. The publication summarizes common billing and coding considerations for S3708, outlines relevant benchmarks where available, and highlights recent policy or coverage updates affecting reimbursement and prior authorization practices.
This resource is intended for billing professionals, coding auditors, and clinical managers seeking a national-level reference for documenting and billing gastrointestinal fat absorption studies. Data not available in the input are indicated where relevant.
Billing Code Overview
HCPCS Level II code S3708 represents a gastrointestinal fat absorption study, a diagnostic service that evaluates intestinal fat absorption and digestion. The service type is diagnostic testing focused on assessment of fat malabsorption or related gastrointestinal disorders. The typical site of service for this study is an outpatient clinic or hospital outpatient department, where specialized laboratory or clinic-based testing and sample collection are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult referred by a gastroenterologist for evaluation of suspected fat malabsorption after months of unexplained steatorrhea, weight loss, bloating, and nutrient deficiencies despite dietary adjustments. Prior outpatient workup includes history, physical exam, basic labs (CBC, CMP), stool studies, and imaging (abdominal ultrasound or CT) that are non-diagnostic. The clinician schedules a gastrointestinal fat absorption study to quantify fecal fat over a timed collection (commonly 72 hours) while the patient is on a standardized high-fat diet. The patient receives pre-test instructions, begins the prescribed diet, and collects stool specimens at home in provided containers over the collection period. Specimens are returned to the laboratory or clinical facility for processing and quantitative analysis of fat content. The laboratory reports total fecal fat grams per collection and interprets results relative to normal reference ranges; these results inform diagnosis of pancreatic exocrine insufficiency, small bowel mucosal disease (for example celiac disease), or bacterial overgrowth. Typical sites of service are outpatient hospital laboratories, freestanding clinical laboratories, or outpatient specialty clinics with specimen handling capability. The ordering provider may be a gastroenterologist, primary care physician, or pediatric gastroenterologist when testing children with similar presentations.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation component separate from the technical/laboratory processing. |